FABLYSE Trademark

Trademark Overview

On Wednesday, November 14, 2018, a trademark application was filed for FABLYSE with the United States Patent and Trademark Office. The USPTO has given the FABLYSE trademark a serial number of 88194104. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 13, 2026. This trademark is owned by Endo Pharmaceuticals Inc.. The FABLYSE trademark is filed in the Pharmaceutical Products category with the following description:

Drug substances, namely, enzymes; pharmaceutical preparations for the treatment of cellulite
fablyse

General Information

Serial Number88194104
Word MarkFABLYSE
Filing DateWednesday, November 14, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 13, 2026
Registration Number5842986
Registration DateTuesday, August 27, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2019

Trademark Statements

Goods and ServicesDrug substances, namely, enzymes; pharmaceutical preparations for the treatment of cellulite

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 13, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameENDO OPERATIONS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressBALLSBRIDGE 4
IE
Party NameEndo Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
US
Party NameEndo Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
US
Party NameEndo Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355
US

Trademark Events

Event DateEvent Description
Saturday, November 17, 2018NEW APPLICATION ENTERED
Sunday, December 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 19, 2019ASSIGNED TO EXAMINER
Friday, February 22, 2019SUSPENSION LETTER WRITTEN
Friday, February 22, 2019LETTER OF SUSPENSION E-MAILED
Friday, February 22, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 26, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, March 31, 2019ASSIGNED TO LIE
Tuesday, April 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 19, 2019NON-FINAL ACTION WRITTEN
Friday, April 19, 2019NON-FINAL ACTION E-MAILED
Friday, April 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 19, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, April 19, 2019EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2019EXAMINER'S AMENDMENT ENTERED
Monday, May 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, June 3, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 22, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 1, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 28, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 27, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 13, 2026CANCELLED SEC. 8 (6-YR)

Related Keywords

fablyse preparations treatment cellulite pharmaceutical enzymes substances namely drug